Higher Dose of Oral Weight-Loss Pill Orforglipron Delivers Greater Results, Meta-Analysis Finds
A new meta-analysis of six randomized controlled trials finds that the 36 mg maintenance dose of the oral GLP-1 agonist ...
A new meta-analysis of six randomized controlled trials finds that the 36 mg maintenance dose of the oral GLP-1 agonist ...
A new study reports that circulating Netrin-4, a developmental guidance protein, is elevated in women with polycystic ovary syndrome and ...
A network meta-analysis of four randomized trials in 14,348 adults with type 2 diabetes finds that higher doses of tirzepatide ...
A post hoc analysis of the SURMOUNT-OSA trials shows that losing at least 10 percent of body weight within the ...
A preclinical study in Nature Metabolism shows that combining the amylin agonist cagrilintide with the triple incretin agonist retatrutide produces ...
Post hoc analyses of the SURMOUNT-OSA trials show tirzepatide improved sleep apnea severity, weight, and blood pressure across all baseline ...
A real-world surveillance study of 259 Taiwanese adults with obesity found that liraglutide produced clinically significant weight loss and a ...
A large real-world study found that adults with type 2 diabetes and atherosclerotic cardiovascular disease who started oral semaglutide had ...
Exit interviews with 74 long-term participants in the SURPASS-CVOT trial reveal that tirzepatide and dulaglutide produced perceived benefits in glycemic ...
A new systematic review and meta-analysis in the International Journal of Obesity examines how subcutaneous semaglutide affects weight and inflammatory ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine